NCT03417583
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
- Vanderbilt Medical Center Nashville, Tennessee, United States
Clinical trial condition
Chorea
Explore clinical trials studying Chorea. Study availability and eligibility vary by location and protocol.
209 public trials
39 recruiting studies
Chorea trial results
Completed
Examination of Quantitative Electroencephalographic (QEEG) Biomarkers in Huntington's Disease
NCT00670709
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
- Locations
-
- UCLA Laboratory of Brain, Behavior,a nd PHarmacology Los Angeles, California, United States
Completed
Making HD Voices Heard
NCT05268029
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
- Huntington Study Group Rochester, New York, United States
NCT00491842
- Conditions
- Basal Ganglia Diseases, Behavior, Brain Diseases, +16 more
- Locations
-
- National Human Genome Research Institute (NHGRI), 9000 Rockville Pike Bethesda, Maryland, United States
NCT05748288
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
- University of Alabama at Birmingham, Department of Neurology Birmingham, Alabama, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- University of California, San Diego La Jolla, California, United States
- Georgetown University Washington D.C., District of Columbia, United States
NCT03515213
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
- University of California, Irvine Irvine, California, United States
NCT03842969
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
- Uab Medicine Birmingham, Alabama, United States
- University of California San Diego La Jolla, California, United States
- Stanford Univ Medical Center Palo Alto, California, United States
- SC3 Research Group, Inc Pasadena, California, United States
Completed
A Study of Pridopidine (ACR16) for the Treatment of Participants With Huntington's Disease
NCT00724048
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California San Diego, California, United States
- Colorado Neurological Institute Littleton, Colorado, United States
- University of South Florida Tampa, Florida, United States
NCT00665223
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
- Locations
-
- LKH -Univ. Klinikum Graz, Universitaetsklinik fur Psychiatrie Graz Graz, Styria, Austria
- Innsbruck Medical University, Anichstraße 35 Innsbruck, Tyrol, Austria
- University Hospital Gasthuisberg Leuven, Flemish Brabant, Belgium
- CHU Roger Salengro Lille, Hauts-de-France, France
Completed
Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease
NCT02507284
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +15 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- UCLA, Neurology Clinic Los Angeles, California, United States
- UC Davis Medical Center, Department of Neurology, CTSC Clinical Research Center Sacramento, California, United States
- University of Colorado Hospital Translational Research Center Aurora, Colorado, United States